Effects of MIF-1 and three related peptides on reserpine-induced hypothermia in mice

[1]  A. Kastin,et al.  Radioimmunoassayable N-Tyr-MIF-1-like activity in rat brain is increased by pinealectomy , 1981, Brain Research Bulletin.

[2]  R. Olson,et al.  Low doses of naloxone and MIF-1 peptides increases fluid consumption in rats , 1981, Pharmacology Biochemistry and Behavior.

[3]  A. Kastin,et al.  Naloxone-like actions of MIF-1 do not require the presence of the pituitary , 1980, Pharmacology Biochemistry and Behavior.

[4]  A. Kastin,et al.  Radioimmunoassay of MIF-1/Tyr-MIF-1-like material in rat pineal , 1980, Pharmacology Biochemistry and Behavior.

[5]  A. Kastin,et al.  Interaction of MIF-I or alpha-MSH with D-amphetamine or chlorpromazine on thermoregulation and motor activity of rats maintained at different ambient temperatures , 1980, Peptides.

[6]  R. Olson,et al.  MIF-I's differential actions as an opiate antagonist , 1979, Pharmacology Biochemistry and Behavior.

[7]  Ehrensing Rh,et al.  Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-I) in depression. , 1978 .

[8]  J. M. Ree,et al.  Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence , 1976 .

[9]  S. Castensson,et al.  Studies on the inhibition of oxotremorine induced tremor by a melanocyte‐stimulating hormone release‐inhibiting factor, thyrotropin releasing hormone and related peptides , 1974, FEBS letters.

[10]  A. Kastin,et al.  Oxotremorine Antagonism by a Hypothalamic Hormone, Melanocyte-Stimulating Hormone Release-Inhibiting Factor (MIF) , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  A. Kastin,et al.  DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF). , 1971, Life sciences. Pt. 1: Physiology and pharmacology.

[12]  B. Askew A SIMPLE SCREENING PROCEDURE FOR IMIPRAMINE-LIKE ANTIDEPRESSANT AGENTS. , 1963, Life sciences.

[13]  J. C. Burke,et al.  Bioassay of Rauwolfia roots and alkaloids. , 1957, The Journal of pharmacology and experimental therapeutics.

[14]  A. Kastin,et al.  Antagonistic actions of MIF-I on the hypothermia and hypomotility induced by beta-endorphin or morphine. , 1980, The International journal of neuroscience.

[15]  L. B. Flexner,et al.  Prolyl-leucyl-glycinamide, cyclo(leucylglycine), and derivatives block development of physical dependence on morphine in mice. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Voith Synthetic MIF analogues. Part II: Dopa potentiation and fluphenazine antagonism. , 1977, Arzneimittel-Forschung.

[17]  A. Kastin,et al.  Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study. , 1974, Archives of general psychiatry.

[18]  A. Kastin,et al.  Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide. , 1973, Neuroendocrinology.